Under construction – not a live service
Sign in
Not yet taking people in AlgeriaNo phase

Studies mouth and saliva markers in adults with stroke

Compares saliva and mouth bacteria markers in adults with stroke and healthy adults.

Plain-language title generated from the registry record
Registry title: Oral and Salivary Biomarkers Associated With Stroke

Key facts

Where
Constantine, AlgeriaSee the 2 sites

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 90 years old?

Source: NCT07357155, who can take part

Where in Algeria

  • Private Dental Clinic, ConstantineConstantine, AlgeriaNo longer taking part
  • University Hospital Center (CHU) of ConstantineConstantine, AlgeriaNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University Hospital Center (CHU) of Constantine, Algeria
Trial code
NCT07357155
Record updated
8 October 2026
Original description
This observational study aims to investigate associations between oral and salivary biomarkers and stroke. Adults with stroke and healthy controls will undergo clinical oral assessment and unstimulated saliva collection. Salivary inflammatory biomarkers and oral bacterial profiles will be analyzed, including detection of Streptococcus mutans and the cnm gene by PCR/qPCR. The study will explore associations between these biomarkers and stroke status.Read full original descriptionShow less

An Observational Study of Oral and Salivary Biomarkers Associated With Stroke

This observational study aims to investigate associations between oral and salivary biomarkers and stroke. Adults with stroke and healthy controls will undergo clinical oral assessment and unstimulated saliva collection. Salivary inflammatory biomarkers and oral bacterial profiles will be analyzed, including detection of Streptococcus mutans and the cnm gene by PCR/qPCR. The study will explore associations between these biomarkers and stroke status.

Inclusion: Adults aged 18 to 90 years; Patients diagnosed with stroke (ischemic or hemorrhagic) confirmed by clinical and imaging criteria for the stroke group; Healthy volunteers without a history of stroke or cerebrovascular disease for the control group; Ability to provide written informed consent.

Exclusion: Recent major surgery or trauma within the last 3 months; inflammatory disease at the time of sampling; Chronic autoimmune or malignant disease; Pregnancy or breastfeeding; Inability or refusal to provide saliva samples.

ClinicalTrials.gov NCT07357155